Skip to main content
. 2024 Jul 25;12(8):1657. doi: 10.3390/biomedicines12081657

Table 5.

The association of rs2046210 with endometriosis risk in patient subpopulations.

Category Patients rs2046210 (GA vs. GG) rs2046210 (GA + AA vs. GG) rs2046210 (GA vs.
GG + AA)
n % OR (95%CI) p-Value OR (95%CI) p-Value OR (95%) p-Value
Stage
low (RAFSI + II) 66 46.8 2.24 (1.11 to 4.51) 0.020 1.78 (0.92 to 3.48) 0.084 2.41 (1.24 to 4.67) 0.007
high (RAFS III + IV) 75 53.2 1.54 (0.78 to 3.03) 0.202 1.43 (0.73 to 2.81) 0.237 1.47 (0.78 to 2.78) 0.230
na 10 6.6
BMI
low (< 25) 161 67.9 2.27 (1.12 to 4.63) 0.018 2.19 (1.12 to 4.29) 0.022 2.01 (1.03 to 3.97) 0.038
high 76 32.1 1.21 (0.43 to 3.41) 0.702 0.93 (0.37 to 2.35) 0.909 1.32 (0.51 to 3.48) 0.556
Age
18–34.9 126 53.2 3.54 (1.47 to 8.60) 0.004 2.63 (1.21 to 5.70) 0.015 3.03 (1.35 to 7.01) 0.006
35–50 111 46.8 1.05 (0.47 to 2.35) 0.920 0.98 (0.46 to 2.10) 0.924 1.11 (0.52 to 2.41) 0.774
Fertility Status
fertile 43 35.5 1.67 (0.47 to 5.96) 0.447 1.11 (0.35 to 3.50) 0.889 2.14 (0.66 to 7.12) 0.203
infertile 78 64.5 3.30 (1.24 to 8.91) 0.016 2.96 (1.22 to 7.22) 0.013 2.79 (1.10 to 7.24) 0.022
na 116 49.0
Gravidity
0 104 51.5 2.41 (0.97 to 6.01) 0.057 2.14 (0.93 to 4.90) 0.072 2.13 (0.92 to 5.05) 0.083
>0 98 48.5 1.42 (0.63 to 3.19) 0.366 1.15 (0.54 to 2.45) 0.778 1.61 (0.74 to 3.49) 0.213
na 35 14.8
Parity
0 144 72.0 1.45 (0.71 to 2.95) 0.326 1.36 (0.69 to 2.66) 0.349 1.43 (0.74 to 2.78) 0.281
>0 56 28.0 2.25 (0.74 to 6.95) 0.141 1.63 (0.61 to 4.37) 0.339 2.37 (0.82 to 6.98) 0.098
na 37 15.6

Odds ratios of the genotypes of rs2046210 in the indicated subcategories are shown. Significant associations are highlighted in bold. OR, odds ratio; 95% CI, 95% confidence interval: RAFS, revised American Fertility Society Score; BMI, bod mass index; na, not assessed.